AAAAAA
Results:
1-14
|
Results: 14
Authors:
PACCHIEROTTI F
ADLER ID
ANDERSON D
BRINKWORTH M
DEMOPOULOS NA
LAHDETIE J
OSTERMANGOLKAR S
PELTONEN K
RUSSO A
TATES A
WATERS R
Citation: F. Pacchierotti et al., GENETIC-EFFECTS OF 1,3-BUTADIENE AND ASSOCIATED RISK FOR HERITABLE DAMAGE, Mutation research. Fundamental and molecular mechanisms of mutagenesis, 397(1), 1998, pp. 93-115
Authors:
PAUWELS W
FARMER PB
OSTERMANGOLKAR S
SEVERI M
CORDERO R
BAILEY E
VEULEMANS H
Citation: W. Pauwels et al., RING TEST FOR THE DETERMINATION OF N-TERMINAL VALINE ADDUCTS OF STYRENE 7,8-OXIDE WITH HEMOGLOBIN BY THE MODIFIED EDMAN DEGRADATION TECHNIQUE, Journal of chromatography B. Biomedical sciences and applications, 702(1-2), 1997, pp. 77-83
Authors:
PEREZ HL
LAHDETIE J
LANDIN HH
KILPELAINEN I
KOIVISTO P
PELTONEN K
OSTERMANGOLKAR S
Citation: Hl. Perez et al., HEMOGLOBIN ADDUCTS OF EPOXYBUTANEDIOL FROM EXPOSURE TO 1,3-BUTADIENE OR BUTADIENE EPOXIDES, Chemico-biological interactions, 105(3), 1997, pp. 181-198
Authors:
PEREZ HL
PLNA K
OSTERMANGOLKAR S
Citation: Hl. Perez et al., DOSIMETRY OF GLYCIDYL ETHERS IN MICE BY QUANTIFICATION OF HEMOGLOBIN ADDUCTS, Chemico-biological interactions, 103(1), 1997, pp. 1-16
Authors:
SORSA M
OSTERMANGOLKAR S
PELTONEN K
SAARIKOSKI ST
SRAM R
Citation: M. Sorsa et al., ASSESSMENT OF EXPOSURE TO BUTADIENE IN THE PROCESS INDUSTRY, Toxicology, 113(1-3), 1996, pp. 77-83
Authors:
OSTERMANGOLKAR S
PELTONEN K
ANTTINENKLEMETTI T
LANDIN HH
ZORCEC V
SORSA M
Citation: S. Ostermangolkar et al., HEMOGLOBIN ADDUCTS AS BIOMARKERS OF OCCUPATIONAL EXPOSURE TO 1,3-BUTADIENE, Mutagenesis, 11(2), 1996, pp. 145-149
Authors:
SORSA M
PELTONEN K
ANDERSON D
DEMOPOULOS NA
NEUMANN HG
OSTERMANGOLKAR S
Citation: M. Sorsa et al., ASSESSMENT OF ENVIRONMENTAL AND OCCUPATIONAL EXPOSURES TO BUTADIENE AS A MODEL FOR RISK-ESTIMATION OF PETROCHEMICAL EMISSIONS, Mutagenesis, 11(1), 1996, pp. 9-17
Authors:
OSTERMANGOLKAR S
BOND JA
Citation: S. Ostermangolkar et Ja. Bond, BIOMONITORING OF 1,3-BUTADIENE AND RELATED-COMPOUNDS, Environmental health perspectives, 104, 1996, pp. 907-915
Authors:
LANDIN HH
OSTERMANGOLKAR S
ZORCEC V
TORNQVIST M
Citation: Hh. Landin et al., BIOMONITORING OF EPICHLOROHYDRIN BY HEMOGLOBIN ADDUCTS, Analytical biochemistry, 240(1), 1996, pp. 1-6
Authors:
ADLER ID
COCHRANE J
OSTERMANGOLKAR S
SKOPEK TR
SORSA M
VOGEL E
Citation: Id. Adler et al., 1,3-BUTADIENE WORKING GROUP-REPORT, Mutation research, 330(1-2), 1995, pp. 101-114
Authors:
OSTERMANGOLKAR S
CHRISTAKOPOULOS A
ZORCEC V
SVENSSON K
Citation: S. Ostermangolkar et al., DOSIMETRY OF STYRENE 7,8-OXIDE IN STYRENE-EXPOSED AND STYRENE OXIDE-EXPOSED MICE AND RATS BY QUANTIFICATION OF HEMOGLOBIN ADDUCTS, Chemico-biological interactions, 95(1-2), 1995, pp. 79-87
Authors:
SEGERBACK D
OSTERMANGOLKAR S
MOLHOLT B
NILSSON R
Citation: D. Segerback et al., IN-VIVO TISSUE DOSIMETRY AS A BASIS FOR CROSS-SPECIES EXTRAPOLATION IN CANCER RISK ASSESSMENT OF PROPYLENE-OXIDE, Regulatory toxicology and pharmacology, 20(1), 1994, pp. 1-14
Authors:
CHRISTAKOPOULOS A
BERGMARK E
ZORCEC V
NORPPA H
MAKIPAAKKANEN J
OSTERMANGOLKAR S
Citation: A. Christakopoulos et al., MONITORING OCCUPATIONAL EXPOSURE TO STYRENE FROM HEMOGLOBIN ADDUCTS AND METABOLITES IN BLOOD, Scandinavian journal of work, environment & health, 19(4), 1993, pp. 255-263
Authors:
NILSSON R
SEGERBACK D
OSTERMANGOLKAR S
Citation: R. Nilsson et al., HUMAN CANCER RISK ASSESSMENT OF PROPYLENE-OXIDE BASED ON DETERMINATION OF TISSUE DOSE IN EXPERIMENTAL-ANIMALS, MUTATION RESEARCH, 291(3), 1993, pp. 260-260
Risultati:
1-14
|